Potential Use of 3D CORAGRAF-Loaded PDGF-BB in PLGA Microsphere Seeded Mesenchymal Stromal Cells in Enhancing the Repair of Calvaria Critical-Size Bone Defect in Rat Model
Authors:
- Saktiswaren MohanSMSaktiswaren Mohan
- Puvanan KarunanithiPKPuvanan Karunanithi
- Malliga Raman MuraliMMMalliga Raman Murali
- Khairul Anwar AyobKAKhairul Anwar Ayob
- Jayaraman MegalaJMJayaraman Megala
- Krishnamurithy GenasanKGKrishnamurithy Genasan
- Tunku KamarulTKTunku Kamarul
- Hanumantha Rao Balaji RaghavendranHRHanumantha Rao Balaji Raghavendran
Open Access
- 31 August 2022
- journal article
- research article
- Published by MDPI AG in Marine Drugs
- Vol. 20 (9) , 561
Abstract
Our previous study evidenced that the 3D CORAGRAF loaded with PLGA microsphere constitutes PDGF-BB can support cell attachment and proliferation and can induce an osteogenic commitment of mesenchymal stromal cells in the in vitro condition. However, how this construct can perform in pathophysiological conditions in terms of repairing critical bone defects is yet to be understood. A study was therefore conducted to investigate the regeneration potential of calvaria critical-size defects using CORAGRAF + PLGA with PDGF-BB + mesenchymal stromal cells (MSCs) in a rat model. A 5 mm critical bone defect was created on calvaria of 40 male Sprague-Dawley rats. CORAGRAF incorporated either with or without PDGF-BB and seeded with rat bone-marrow-derived MSCs was implanted at the defect region. The bone regeneration potential of implanted constructs was assessed using micro-CT imaging and histological staining in weeks 4 and 8. The micro-CT images indicated a significant closure of defects in the cranial bone of the rats treated with 3D CORAGRAF + PLGA with PDGF-BB + MSCs on week 4 and 8 post-implantation. This finding, further supported with the histology outcome where the rat cranial defect treated with CORAGRAF + PLGA with PDGF-BB + MSCs indicated neo-bony ingrowth with organized and mature bone-like morphology as compared with other groups. The previous in vitro results substantiated with our pre-clinical findings demonstrate that the combination of CORAGRAF + PLGA with PDGF-BB + MSCs could be an ideal construct to support bone regeneration in critical bone defects. Hence, this construct can be further investigated for its safety and efficacy in large animal models, or it can be skipped to human trial prior for commercialization.Keywords
Funding Information
- Ministry of Higher Education (FRGS/1/2020/SKK0/UM/03/2)
This publication has 44 references indexed in Scilit:
- Cranial bone defects: current and future strategiesNeurosurgical Focus, 2010
- Endothelial cells incubated with platelet‐rich plasma express PDGF‐B and ICAM‐1 and induce bone marrow stromal cell migrationJournal of Orthopaedic Research, 2009
- Delivery of ofloxacin to the lung and alveolar macrophages via hyaluronan microspheres for the treatment of tuberculosisJournal of Controlled Release, 2008
- Effect Of Structural Relaxation On The Preparation And Drug Release Behavior Of Poly(lactic-co-glycolic)acid Microparticle Drug Delivery SystemsJournal of Pharmaceutical Sciences, 2008
- Engineering Biodegradable Polyester Particles With Specific Drug Targeting and Drug Release PropertiesJournal of Pharmaceutical Sciences, 2008
- Influence of the Porosity of Starch-Based Fiber Mesh Scaffolds on the Proliferation and Osteogenic Differentiation of Bone Marrow Stromal Cells Cultured in a Flow Perfusion BioreactorTissue Engineering, 2006
- Bone Graft MaterialsClinical Orthopaedics and Related Research, 2000
- Collagen microparticles: carriers for glucocorticosteroidsEuropean Journal of Pharmaceutics and Biopharmaceutics, 1998
- Coralline Hydroxyapatite Bone Graft SubstitutesInvestigative Radiology, 1996
- Coralline Hydroxyapatite Bone-Graft Substitutes in a Canine Diaphyseal Defect ModelInvestigative Radiology, 1987